Article
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy.
Journal of the American College of Cardiology - 28 Jun 2011
Dai Dao-Fu, Chen Tony, Szeto Hazel, Nieves-Cintrón Madeline, Kutyavin Vassily, Santana Luis F, Rabinovitch Peter S
Abstract excerpt
OBJECTIVES: We investigated the effect of reducing mitochondrial oxidative stress by the mitochondrial-targeted antioxidant peptide SS-31 in hypertensive cardiomyopathy. BACKGROUND: Oxidative stress has been implicated in hypertensive cardiovascular diseases. Mitochondria and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase have been proposed as primary sites of reactive oxygen species (ROS)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
